改良GAP指数预测非小细胞肺癌合并特发性肺纤维化急性加重
本研究回顾性分析43例非小细胞肺癌合并特发性肺纤维化患者,采用基于性别、年龄和预测用力肺活量百分比的改良GAP分期系统评估疾病临床过程中急性加重发生率及预后。结果显示17例(40%;95%CI:26-54%)发生急性加重,1年生存率41.9%(95%CI:28-57%),中位总生存期9.4个月,且随mGAP评分和分期升高,急性加重发生率逐渐增加、生存率逐渐下降。提示mGAP指数评分和癌症分期可能预测此类患者急性加重及预后。
要点
- 43例NSCLC合并IPF患者中40%(95%CI:26-54%)发生IPF急性加重
- 1年生存率41.9%(95%CI:28-57%),中位总生存期9.4个月
- mGAP评分和分期越高,急性加重发生率越高、生存率越低
核心结论
- mGAP指数评分和癌症分期可能预测NSCLC合并IPF患者的IPF急性加重及预后。
研究设计与样本
- 回顾性研究,最终分析纳入43例非小细胞肺癌合并特发性肺纤维化患者。
- 采用基于性别、年龄和预测用力肺活量百分比的改良GAP(mGAP)分期系统进行比较。
主要发现
- 43例中有17例(40%;95%CI:26-54%)在疾病临床过程中发生IPF急性加重。
- 1年生存率为41.9%(95%CI:28-57%),中位总生存期为9.4个月。
- 随mGAP指数评分和分期升高,IPF急性加重发生率逐渐增加,1年生存率和中位总生存期逐渐下降。
临床怎么用
- 可考虑使用mGAP指数评分联合癌症分期对NSCLC合并IPF患者进行急性加重和预后风险评估。
局限性
- 回顾性研究,样本量43例,结论需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Predicting the incidence rate of acute exacerbation (AE) of idiopathic pulmonary fibrosis (IPF) and its prognosis in patients with non-small cell lung cancer (NSCLC) and IPF is difficult. The aim was to study the incidence of IPF-AE during the clinical course of the disease and its prognosis in patients with both NSCLC and IPF. METHODS: In this retrospective study, we compared the incidence rate of AE during the clinical course of the disease as well as the 1-year survival rate and overall survival (OS) of patients with NSCLC and IPF using a modified gender, age and physiology (mGAP) staging system based on gender, age and percent predicted forced vital capacity. RESULTS: Of 43 patients with NSCLC and IPF included in the final analysis, 17 patients (40%; 95% CI: 26-54%) experienced AE during the clinical course of the disease. One-year survival and median OS were 41.9% (95% CI: 28-57%) and 9.4 months, respectively. Further analysis showed that the incidence of IPF-AE gradually increased and that the 1-year survival rate and median OS gradually decreased with increasing mGAP index score and stage. CONCLUSION: Our study suggested that mGAP index score and cancer stage may predict IPF-AE and its prognosis in patients with NSCLC and IPF.
引用
- Kobayashi H, Omori S, Nakashima K, et al. Modified GAP index for prediction of acute exacerbation of idiopathic pulmonary fibrosis in non-small cell lung cancer. Respirology. 2017. PMID: 28543987. doi:10.1111/resp.13075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。